New-onset eosinophilic granulomatosis with polyangiitis in 2 patients during treatment with IL-5 pathway inhibitors.

Holubar J, Arnaud E, Broner J, Pers YM, Proust A, Goulabchand R

Open source

DOI
10.1007/s12026-022-09317-5
Published
2022 Dec
Container
Immunologic research
Publisher
Not recorded
Open access
no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1007/s12026-022-09317-5,
  title = {New-onset eosinophilic granulomatosis with polyangiitis in 2 patients during treatment with IL-5 pathway inhibitors.},
  author = {Holubar J and Arnaud E and Broner J and Pers YM and Proust A and Goulabchand R},
  year = {2022},
  journal = {Immunologic research},
  doi = {10.1007/s12026-022-09317-5},
  url = {https://doi.org/10.1007/s12026-022-09317-5}
}

RIS

TY  - JOUR
TI  - New-onset eosinophilic granulomatosis with polyangiitis in 2 patients during treatment with IL-5 pathway inhibitors.
AU  - Holubar J
AU  - Arnaud E
AU  - Broner J
AU  - Pers YM
AU  - Proust A
AU  - Goulabchand R
PY  - 2022
JO  - Immunologic research
DO  - 10.1007/s12026-022-09317-5
UR  - https://doi.org/10.1007/s12026-022-09317-5
ER  - 

APA

J, H., E, A., J, B., YM, P., A, P., & R, G. (2022). New-onset eosinophilic granulomatosis with polyangiitis in 2 patients during treatment with IL-5 pathway inhibitors.. Immunologic research. https://doi.org/10.1007/s12026-022-09317-5

Source records